Etanercept works for psoriasis patients after they lose response to adalimumab

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Takeaway
  • Patients with moderate-to-severe psoriasis who stopped responding to adalimumab (Humira) had a satisfactory response to etanercept (Enbrel) even if they had anti-adalimumab antibodies (ADA).
Why this matters
  • Some patients who take TNF inhibitor therapy lose response to them over time.
St...